97 reports

  • Increase in incidence of pulmonary hypertension (PH)
  • 66 GLOBAL PULMONARY ARTERIAL HYPERTENSION DRUGS MARKET 2017-2021
  • Hypertension
  • Actelion Ltd
  • Daiichi Sankyo Company
  • Novartis AG
  • United Therapeutics Corporation
  • Global pulmonary hypertension market: 2014-2019 ($ billions)
  • Strength
  • Hypertension
  • Actelion Ltd
  • Bayer AG
  • GlaxoSmithKline plc
  • United Therapeutics Corporation
  • Systemic hypertension
  • PULMONARY ARTERIAL HYPERTENSION KEY METRICS IN THE 7MM
  • Hypertension
  • Forecast
  • Actelion Ltd
  • GlobalData's company
  • United Therapeutics Corporation
  • Hypertension Drugs Sales Volume
  • V. HYPERTENSION DRUGS MARKET OUTLOOK
  • Hypertension
  • China
  • Demand
  • Market Size
  • Sanofi-Synthelabo Inc.
  • Hypertension Drugs Sales Volume by Drugs
  • Hypertension Drugs Sales Volume by Drugs
  • Hypertension
  • China
  • Demand
  • Market Size
  • Trade
  • ANTI-HYPERTENSIVE THERAPEUTICS, TREATMENT ALGORITHM OF HYPERTENSION
  • ANTI-HYPERTENSIVE THERAPEUTICS, DEFINITIONS OF HYPERTENSION BY OFFICE AND OUT-OF-
  • Hypertension
  • World
  • Market Size
  • Daiichi Sankyo Company
  • Novartis AG
  • Pulmonary Arterial Hypertension: Executive Summary
  • 4.1 BIBLIOGRAPHY
  • Hypertension
  • France
  • Germany
  • Japan
  • Forecast

Key Features of the Report: - Hypertension Patient Flow - Hypertension Prevalence - Hypertension Diagnosed Patients - Hypertension Treated Patients

  • Hypertension
  • Europe
  • France
  • World
  • Forecast

Key Features of the Report: - Plumonary Arterial Hypertension Patient Flow - Plumonary Arterial Hypertension Prevalence - Plumonary Arterial Hypertension Diagnosed Patients - Plumonary Arterial Hypertension Treated Patients

  • Hypertension
  • Europe
  • France
  • World
  • Forecast
  • Hypertension Drugs Industry Structure
  • Hypertension Drugs Sales Volume
  • Hypertension
  • China
  • AstraZeneca China Inc.
  • Hangzhou MSD Pharmaceutical Co., Ltd
  • Sanofi-Synthelabo Inc.

Hypertension Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Hypertension Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hypertension pipeline products, Hypertension epidemiology,

  • Hypertension
  • France
  • Germany
  • Italy
  • Market Size

Hypertension is classified into two types: - Primary or essential hypertension: It is defined as high BP with no known cause, and includes around ##%-##% of all hypertension cases - Secondary hypertension: It is high BP with a known direct cause, including kidne

  • Chronic Disease
  • Hypertension
  • Pathology
  • World
  • Market Size

Pulmonary Hypertension Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Pulmonary Hypertension Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Pulmonary Hypertension pipeline products, Pulmonary

  • Hypertension
  • France
  • Germany
  • Italy
  • Market Size

Key Features of the Report: - Pulmonary Arterial Hypertension: Disease Definition - Pulmonary Arterial Hypertension Patient Flow - Pulmonary Arterial Hypertension Prevalence - Pulmonary Arterial Hypertension Diagnosed Patients - Pulmonary Arterial

  • Hypertension
  • Europe
  • France
  • World
  • Forecast

Key Features of the Report: - Hypertension Patient Flow - Hypertension Prevalence - Hypertension Diagnosed Patients - Hypertension Treated Patients

  • Hypertension
  • Europe
  • France
  • Germany
  • Forecast

Key Features of the Report: - Plumonary Arterial Hypertension Patient Flow - Plumonary Arterial Hypertension Prevalence - Plumonary Arterial Hypertension Diagnosed Patients - Plumonary Arterial Hypertension Treated Patients

  • Hypertension
  • Europe
  • France
  • Germany
  • Forecast
  • Hypertension classification
  • Hypertension Status
  • Chronic Disease
  • Hypertension
  • Pathology
  • Asia
  • Europe
  • Pipeline: Pulmonary Arterial Hypertension
  • FORECAST: PULMONARY ARTERIAL HYPERTENSION
  • Hypertension
  • Europe
  • Actelion Ltd
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc

Pulmonary Arterial Hypertension Overview • Pulmonary Arterial Hypertension Definition • Pathophysiology • Symptoms • Etiology ##.

  • Hypertension
  • France
  • Germany
  • Italy
  • Japan

Hypertension Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Hypertension Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hypertension pipeline products, Hypertension epidemiology,

  • Hypertension
  • Europe
  • France
  • Germany
  • Market Size

Japan Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hypertension Treatments ##) Hypertension Pipeline ##) Japan Hypertension Epidemiology ##) Marketed Drugs for

  • Chronic Disease
  • Hypertension
  • Japan
  • Demand
  • Market Size

Germany Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hypertension Treatments ##) Hypertension Pipeline ##) Germany Hypertension Epidemiology ##) Marketed Drugs for

  • Chronic Disease
  • Hypertension
  • Germany
  • Demand
  • Market Size

Italy Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hypertension Treatments ##) Hypertension Pipeline ##) Italy Hypertension Epidemiology ##) Marketed Drugs for

  • Chronic Disease
  • Hypertension
  • Italy
  • Demand
  • Market Size

UK Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hypertension Treatments ##) Hypertension Pipeline ##) UK Hypertension Epidemiology ##) Marketed Drugs for Hypertension in UK

  • Chronic Disease
  • Hypertension
  • Pathology
  • United Kingdom
  • Market Size

France Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hypertension Treatments ##) Hypertension Pipeline ##) France Hypertension Epidemiology ##) Marketed Drugs for

  • Chronic Disease
  • Hypertension
  • France
  • Demand
  • Market Size

US Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hypertension Treatments ##) Hypertension Pipeline ##) US Hypertension Epidemiology ##) Marketed Drugs for Hypertension in US

  • Chronic Disease
  • Hypertension
  • Pathology
  • Market Size

Spain Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hypertension Treatments ##) Hypertension Pipeline ##) Spain Hypertension Epidemiology ##) Marketed Drugs for

  • Chronic Disease
  • Hypertension
  • Spain
  • Demand
  • Market Size

Pulmonary Hypertension Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Pulmonary Hypertension Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Pulmonary Hypertension pipeline products, Pulmonary

  • Hypertension
  • Europe
  • France
  • Germany
  • Market Size

Japan Pulmonary Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Pulmonary Hypertension Treatments ##) Pulmonary Hypertension Pipeline ##) Japan Pulmonary Hypertension Epidemiology ##)

  • Chronic Disease
  • Hypertension
  • Pathology
  • Japan
  • Market Size

Italy Pulmonary Hypertension Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Pulmonary Hypertension Treatments ##) Pulmonary Hypertension Pipeline ##) Italy Pulmonary Hypertension Epidemiology ##)

  • Chronic Disease
  • Hypertension
  • Pathology
  • Italy
  • Market Size